Evolent Health Inc
For the period ended Dec 31, 2023. Filed Feb 23, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 23, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Evolent Health, Inc. | |
| By: | /s/ John Johnson |
|---|---|
| Name: | John Johnson |
| Title: | Chief Financial Officer |
Dated: February 22, 2024
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Seth Blackley | Chief Executive Officer and Director | February 22, 2024 |
| Seth Blackley | (Principal Executive Officer) | |
| /s/ John Johnson | Chief Financial Officer | February 22, 2024 |
| John Johnson | (Principal Financial Officer) | |
| /s/ Aammaad Shams | Chief Accounting Officer | February 22, 2024 |
| Aammaad Shams | (Principal Accounting Officer) | |
| /s/ Toyin Ajayi | Director | February 22, 2024 |
| Toyin Ajayi, MD | ||
| /s/ Craig Barbarosh | Director | February 22, 2024 |
| Craig Barbarosh | ||
| /s/ M. Bridget Duffy | Director | February 22, 2024 |
| M. Bridget Duffy, MD | ||
| /s/ Russell Glass | Director | February 22, 2024 |
| Russell Glass | ||
| /s/ Peter Grua | Director | February 22, 2024 |
| Peter Grua | ||
| /s/ Diane Holder | Director | February 22, 2024 |
| Diane Holder | ||
| /s/ Richard Jelinek | Director | February 22, 2024 |
| Richard Jelinek | ||
| /s/ Kim Keck | Director | February 22, 2024 |
| Kim Keck | ||
| /s/ Cheryl Scott | Director | February 22, 2024 |
| Cheryl Scott | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.